Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.4%

16 terminated/withdrawn out of 170 trials

Success Rate

84.2%

-2.3% vs industry average

Late-Stage Pipeline

9%

15 trials in Phase 3/4

Results Transparency

1%

1 of 85 completed trials have results

Key Signals

30 recruiting1 with results16 terminated

Enrollment Performance

Analytics

N/A
70(55.6%)
Phase 2
29(23.0%)
Phase 3
13(10.3%)
Phase 1
11(8.7%)
Phase 4
2(1.6%)
Early Phase 1
1(0.8%)
126Total
N/A(70)
Phase 2(29)
Phase 3(13)
Phase 1(11)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (170)

Showing 20 of 170 trials
NCT07571564Recruiting

Adherence to Enteral Nutrition

Role: lead

NCT05293197Phase 1Recruiting

Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients

Role: collaborator

NCT05354765Not ApplicableRecruiting

Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA

Role: lead

NCT05475366Not ApplicableRecruiting

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures

Role: lead

NCT06581809Not ApplicableTerminated

Comparative Evaluation of Care Strategies on Dressing Change-induced Bleeding in Patients With Bleeding Malignant Wounds (Tumoss)

Role: lead

NCT04731610Not ApplicableRecruiting

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)

Role: lead

NCT06195709Phase 3Recruiting

ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients

Role: lead

NCT07532668Completed

Multicentre Retrospective Cohort Study of Palliative Care Pathways in Patients Who Died From Sarcoma

Role: collaborator

NCT07491380Not ApplicableNot Yet Recruiting

Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)

Role: lead

NCT06659705Phase 2Recruiting

Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)

Role: lead

NCT05088395Not ApplicableRecruiting

Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4

Role: lead

NCT05931302Not ApplicableActive Not Recruiting

Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT

Role: collaborator

NCT06007274Completed

Troponin to Detect Major Cardiovasculaire Advserse Events on Immune Checkpoint Inhibitors

Role: collaborator

NCT02867033Not ApplicableActive Not Recruiting

National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

Role: collaborator

NCT07193394Phase 2Recruiting

Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer

Role: lead

NCT05781295Not ApplicableRecruiting

Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology

Role: lead

NCT06175390Phase 2Active Not Recruiting

Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer

Role: lead

NCT03017573Not ApplicableRecruiting

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

Role: lead

NCT05439005Phase 3Recruiting

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.

Role: lead

NCT06459791Not ApplicableRecruiting

Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)

Role: lead